Conversations from CROI 2013: CDC’s Dr. Jonathan Mermin

Content From: Ronald Valdiserri, M.D., M.P.H., Deputy Assistant Secretary for Health, Infectious Diseases, and Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human ServicesPublished: March 21, 20131 min read


During the 2013 Conference on Retroviruses and Opportunistic InfectionsExit Disclaimer (CROI) in Atlanta earlier this month, I had the opportunity to sit down with Dr. Jonathan Mermin, Director of CDC’s Division of HIV/AIDS Prevention. We discussed some of the important research findings being shared at the conference and their implications for our efforts to respond effectively to HIV/AIDS in the United States. Watch our conversation below about two important studies presented. We discuss the importance of medication adherence for people using antiretrovirals for pre-exposure prophylaxis (PrEP) as well as new CDC data indicating that far too few adults in care for HIV disease are receiving the recommended screening and prevention services related to other sexually transmitted infections (STIs), which can threaten their health and facilitate further HIV transmission.

To learn more about the findings from the VOICE study of pre-exposure prophylaxis shared at CROI, read the abstract,watch the presentationExit Disclaimer (beginning at 00:30:32) and review our related blog post or view the posterExit Disclaimer.